Related Experiment Video
Updated: Aug 4, 2026
07:37
Mouse Models for Graft Arteriosclerosis
Published on: May 14, 2013
Heparin-protamine mismatch. A controllable factor in bleeding after open heart surgery
G A DeLaria1, J J Tyner, C L Hayes
1Division of Cardiac Surgery, Scripps Clinic, La Jolla, Calif.
Archives of Surgery (Chicago, Ill. : 1960)
|September 1, 1994
Summary
A new system to reduce heparin-protamine mismatch significantly lowered protamine sulfate doses in open heart surgery. This led to less blood product use and reduced postoperative bleeding, avoiding reoperations.
Area of Science:
- Cardiovascular Surgery
- Anesthesiology
- Hematology
Background:
- Heparin and protamine sulfate are critical for managing anticoagulation and its reversal during open heart surgery.
- Heparin-protamine mismatch can lead to increased blood product transfusion and postoperative bleeding.
- Optimizing protamine dosing is essential to minimize complications and improve patient outcomes.
Purpose of the Study:
- To evaluate a novel system designed to minimize heparin-protamine mismatch.
- To assess the impact of this system on postoperative bleeding and blood product requirements.
- To determine if a reduced protamine dose is associated with improved surgical outcomes.
Main Methods:
- A retrospective review of 150 patients undergoing open heart surgery.
- Group 1 (n=75) received a fixed heparin-protamine ratio.
- Group 2 (n=75) received titrated heparin and protamine based on activated clotting times and drug lot matching.
Main Results:
- Patients receiving titrated protamine (Group 2) required significantly lower doses (287.56 mg vs 346.01 mg).
- Group 2 showed reduced transfusion of red blood cells, platelets, and fresh-frozen plasma.
- No patients in Group 2 needed reoperation for bleeding, compared to eight in Group 1.
Conclusions:
- Reducing protamine sulfate dose through optimized titration significantly decreases blood product use.
- Minimized heparin-protamine mismatch is linked to reduced postoperative bleeding after open heart surgery.
- Excess protamine is a controllable factor contributing to coagulopathy, warranting careful management.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:05Introduction to Hemostasis
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
01:20Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
01:24Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
01:23Peripheral Artery Disease V: Postoperative Nursing Management
During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...